>
The Fear-Mongering Rackets of the US National-Security State
Gen-Z flexes new-age political muscle in Nepal
Trump to sign EO directing investigation of 'crypto' debanking: report
Methylene chloride (CH2Cl?) and acetone (C?H?O) create a powerful paint remover...
Engineer Builds His Own X-Ray After Hospital Charges Him $69K
Researchers create 2D nanomaterials with up to nine metals for extreme conditions
The Evolution of Electric Motors: From Bulky to Lightweight, Efficient Powerhouses
3D-Printing 'Glue Gun' Can Repair Bone Fractures During Surgery Filling-in the Gaps Around..
Kevlar-like EV battery material dissolves after use to recycle itself
Laser connects plane and satellite in breakthrough air-to-space link
Lucid Motors' World-Leading Electric Powertrain Breakdown with Emad Dlala and Eric Bach
Murder, UFOs & Antigravity Tech -- What's Really Happening at Huntsville, Alabama's Space Po
The report analyses the science and ethics behind the Health Resources and Services Administration's (HRSA) proposed rule to redefine hematopoietic (blood-forming) stem cells (HSC) as an organ. These are the cells that originate in bone marrow but are also found in the bloodstream. Today, over 70% of HSC donations are extracted from the bloodstream through a safe, non-invasive technique known as apheresis, after which the cells quickly regenerate.
In 2011, a federal court ruled compensating donors of HSC by apheresis to be legal due to the procedure's comparability to plasma and whole blood donation. HRSA's rule change would supersede the court and violate congressional intent, thereby making compensation to all HSC donors illegal under the National Organ Transplant Act. HRSA has until December 18th to move forward on its rule.